These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 17063439

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Fighting malignancy in organ transplant recipients.
    Geissler EK.
    Transplant Proc; 2009; 41(6 Suppl):S9-12. PubMed ID: 19651298
    [Abstract] [Full Text] [Related]

  • 5. [Minimizing the risk of cancer in transplant patients].
    Campistol JM.
    G Ital Nefrol; 2010; 27 Suppl 50():S81-5. PubMed ID: 20922701
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppression and tumor development in organ transplant recipients: the emerging dualistic role of rapamycin.
    Gaumann A, Schlitt HJ, Geissler EK.
    Transpl Int; 2008 Mar; 21(3):207-17. PubMed ID: 18069922
    [Abstract] [Full Text] [Related]

  • 7. Strategies for minimizing immunosuppression in kidney transplantation.
    Kirk AD, Mannon RB, Swanson SJ, Hale DA.
    Transpl Int; 2005 Jan; 18(1):2-14. PubMed ID: 15612977
    [Abstract] [Full Text] [Related]

  • 8. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL.
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [Abstract] [Full Text] [Related]

  • 9. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
    Pretagostini R, Cinti P, Lai Q, Poli L, Berloco PB.
    Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
    [Abstract] [Full Text] [Related]

  • 10. [Post-transplantation malignant tumors and the challenges of immunosuppressive therapy in transplanted patients developing lymphoma. Mycophenolic acid as a possibility].
    Végso G.
    Magy Onkol; 2009 Jun; 53(2):149-56. PubMed ID: 19581181
    [Abstract] [Full Text] [Related]

  • 11. [After care following kidney transplantation].
    Steinhäuslin F.
    Schweiz Rundsch Med Prax; 1994 May 31; 83(22):680-3. PubMed ID: 8016506
    [Abstract] [Full Text] [Related]

  • 12. Can immunosuppressive strategies be used to reduce cancer risk in renal transplant patients?
    Geissler EK.
    Transplant Proc; 2010 Nov 31; 42(9 Suppl):S32-5. PubMed ID: 21095449
    [Abstract] [Full Text] [Related]

  • 13. New immunosuppressive drugs for prevention and treatment of rejection in renal transplant.
    Segoloni GP, Quaglia M.
    J Nephrol; 2006 Nov 31; 19(5):578-86. PubMed ID: 17136684
    [Abstract] [Full Text] [Related]

  • 14. Effect of cyclosporin A on DNA repair and cancer incidence in kidney transplant recipients.
    Herman M, Weinstein T, Korzets A, Chagnac A, Ori Y, Zevin D, Malachi T, Gafter U.
    J Lab Clin Med; 2001 Jan 31; 137(1):14-20. PubMed ID: 11150019
    [Abstract] [Full Text] [Related]

  • 15. Malignancy after kidney transplantation: results of 400 patients from a single center.
    Stratta P, Morellini V, Musetti C, Turello E, Palmieri D, Lazzarich E, Cena T, Magnani C.
    Clin Transplant; 2008 Jan 31; 22(4):424-7. PubMed ID: 18312442
    [Abstract] [Full Text] [Related]

  • 16. Prevention of acute rejection with antithymocyte globulin (Thymoglobuline): its potential to reduce corticosteroids.
    Cantarovich D.
    J Nephrol; 2004 Jan 31; 17 Suppl 8():S40-6. PubMed ID: 15599885
    [Abstract] [Full Text] [Related]

  • 17. The impact of mTOR inhibitors on the development of malignancy.
    Geissler EK.
    Transplant Proc; 2008 Dec 31; 40(10 Suppl):S32-5. PubMed ID: 19100904
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.